Tirzepatide: Does the Evidence to Date Show Potential for the Treatment of Early Stage Type 2 Diabetes?

Autor: Razzaki, Tanzila S (AUTHOR), Weiner, Alyson (AUTHOR), Shukla, Alpana P (AUTHOR)

Publikováno v: Therapeutics & Clinical Risk Management. Sep2022, Vol. 18, p955-964. 10p.

Abstract #799941: Ectopic Cushing’s Syndrome Presenting with Resistant Hypokalemia, Metabolic Alkalosis and Muscle Wasting

Autor: Razzaki, Tanzila

Publikováno v: In Endocrine Practice May 2020 26 Supplement 2:6-7

Abstract #448 Transient Hepatotoxicity and Hypertriglyceridemia Seen After Over the Counter Testosterone Booster Supplement

Autor: Razzaki, Tanzila, Raghuwanshi, Maya

Publikováno v: In Endocrine Practice April 2019 25 Supplement 1:216-216

Abstract #319: Internal Medicine Residents’ Practice Regarding Treatment of Hyperglycemia in Non-Critically Ill Inpatients with Diabetes

Autor: Aleksic, Sandra, Zhai, Elaine, Razzaki, Tanzila, Wang, Zhen, Kibola, Adam, Kothari, Neil, Feurdean, Mirela

Publikováno v: In Endocrine Practice May 2016 22 Supplement 2:97-97

Inverse Association between Serotonin 2A Receptor Antagonist Medication Use and Mortality in Severe COVID-19 Infection.

Autor: Zimering MB; Medical Service, Veterans Affairs New Jersey Healthcare System, East Orange, New Jersey, USA.; Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Razzaki T; Medical Service, Veterans Affairs New Jersey Healthcare System, East Orange, New Jersey, USA.; Rutgers-New Jersey Medical School, Newark, New Jersey, USA., Tsang T; Medical Service, Veterans Affairs New Jersey Healthcare System, East Orange, New Jersey, USA.; Rutgers-New Jersey Medical School, Newark, New Jersey, USA., Shin JJ; Medical Service, Veterans Affairs New Jersey Healthcare System, East Orange, New Jersey, USA.; Rutgers-New Jersey Medical School, Newark, New Jersey, USA.

Publikováno v: Endocrinology, diabetes and metabolism journal [Endocrinol Diabetes Metab J] 2020 Sep 15; Vol. 4 (4), pp. 1-5.